Literature DB >> 12065691

Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry.

Cristina Miki Hayashi1, Ryoji Nagai, Kiminori Miyazaki, Fumitaka Hayase, Tomohiro Araki, Tomomichi Ono, Seikoh Horiuchi.   

Abstract

Accumulation of advanced glycation end products (AGE) of the Maillard reaction increases by aging and in age-enhanced diseases such as atherosclerosis and diabetic complications. Immunohistochemical analysis has been used to demonstrate AGE in vivo. In immunochemistry, the heat-induced epitope retrieval technique is extensively used with formalin-fixed, paraffin-embedded tissue sections. Here we examined whether AGE could be formed artificially through the heating process. Normal rat skin and liver samples were divided into two groups, one rapidly frozen, the other formalin-fixed, paraffin-embedded and submitted to heat-induced epitope retrieval treatment. In heat-treated sections, the cytoplasm of rat epidermal cells and hepatocytes were strongly stained by monoclonal antibody against N(epsilon)-(carboxymethyl)lysine (CML), while the staining was negligible in either frozen sections or in paraffin-embedded but heat-untreated sections. To clarify the mechanism, we conducted heat treatment to glycated human serum albumin (HSA), a model Amadori protein, and generation of CML was determined by immunochemical and HPLC analysis. CML was generated from glycated HSA by heat treatment (above 80 degrees C) and increased in a time-dependent manner. In contrast, generation of CML from glycated HSA was significantly inhibited in the presence of NaBH4, a reducing agent, diethylenetriamine pentaacetic acid, a chelator of transition metal ion, or aminoguanidine, a trapping reagent for alpha-oxoaldehydes. Furthermore, heat-induced CML formation in rat liver samples determined by HPLC was markedly reduced by pretreatment with NaBH4. Reactive intermediates such as glucosone, 3-deoxyglucosone, methylglyoxal, and glyoxal were formed upon heat treatment of glycated HSA at 100 degrees C, indicating that these aldehydes generated from Amadori products by oxidative cleavage can contribute to further CML formation. CML generated by heating, directly from Amadori products or via these aldehydes, might serve as an artifact upon immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065691     DOI: 10.1097/01.lab.0000018826.59648.07

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Authors:  S Gadau; C Emanueli; S Van Linthout; G Graiani; M Todaro; M Meloni; I Campesi; G Invernici; F Spillmann; K Ward; P Madeddu
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

2.  DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.

Authors:  Richard Jaramillo; Sarah C Shuck; Yin S Chan; Xueli Liu; Steven E Bates; Punnajit P Lim; Daniel Tamae; Sandrine Lacoste; Timothy R O'Connor; John Termini
Journal:  Chem Res Toxicol       Date:  2017-02-03       Impact factor: 3.739

3.  Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Andrew Soulby; Isolda Romero Canelon; Mark Barrow; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-10-15       Impact factor: 3.109

Review 4.  Antibody-based detection of advanced glycation end-products: promises vs. limitations.

Authors:  Ryoji Nagai; Jun-Ichi Shirakawa; Rei-Ichi Ohno; Kota Hatano; Hikari Sugawa; Shoutaro Arakawa; Kenta Ichimaru; Shoh Kinoshita; Noriyuki Sakata; Mime Nagai
Journal:  Glycoconj J       Date:  2016-07-15       Impact factor: 2.916

5.  Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats.

Authors:  Rei-Ichi Ohno; Kenta Ichimaru; Seitaro Tanaka; Hikari Sugawa; Nana Katsuta; Shiori Sakake; Yu-Ki Tominaga; Ikuho Ban; Jun-Ichi Shirakawa; Yoshiki Yamaguchi; Emi Ito; Naoyuki Taniguchi; Ryoji Nagai
Journal:  J Biol Chem       Date:  2019-10-08       Impact factor: 5.157

6.  Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.

Authors:  Morgan L Zenner; Yves B Helou; Ryan J Deaton; Maria Sverdlov; Heng Wang; Andre Kajdacsy-Balla; Virgilia Macias; Cindy Voisine; Marcus Murray; Sarki A Abdulkadir; Adam B Murphy; Larisa Nonn
Journal:  Prostate       Date:  2021-12-02       Impact factor: 4.104

7.  Use of human vascular tissue microarrays for measurement of advanced glycation endproducts.

Authors:  Marc K Halushka; Elizabeth Selvin; Jie Lu; Anne M Macgregor; Toby C Cornish
Journal:  J Histochem Cytochem       Date:  2009-02-16       Impact factor: 2.479

Review 8.  Detection of AGEs as markers for carbohydrate metabolism and protein denaturation.

Authors:  Ryoji Nagai; Jun-Ichi Shirakawa; Yukio Fujiwara; Rei-Ichi Ohno; Narumi Moroishi; Noriyuki Sakata; Mime Nagai
Journal:  J Clin Biochem Nutr       Date:  2014-07-01       Impact factor: 3.114

9.  Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction.

Authors:  Bianca de Moraes Fracasso; Juliana Oliveira Rangel; Alessandra Gonçalves Machado; Fernanda Severo Curuja; Amanda Lopes; Virgílio Olsen; Nadine Clausell; Andreia Biolo; Luis Eduardo Rohde; Michael Andrades
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

Review 10.  Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects.

Authors:  Anna Perrone; Antonio Giovino; Jubina Benny; Federico Martinelli
Journal:  Oxid Med Cell Longev       Date:  2020-03-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.